Association of TGIFLX/Y mRNA expression with prostate cancer.
Tehrān, Iran. In Med Oncol, 2008
most prostate tumors (73.5%) express at least one of these genes (TGIFLX and TGIFLY), although different patterns of mRNA expression were observed. These results suggest an association of TGIFLX/Y expression with the progression of prostate cancer.